MCGLYNN MARGARET G has filed 31 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 18884 shares of NOVAVAX INC ($NVAX) on June 20, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | A | Restricted Stock Units | 18884 | $0.00 | 18,884.0000 | 152,190,000 | 9999.99% | 0.01% |
| June 20, 2025 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | A | Stock Option (Right to Buy) | 28326 | $6.42 | 28,326.0000 | 152,190,000 | 9999.99% | 0.02% |
| June 12, 2025 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Not found | M | Common Stock | 10420 | $0.00 | 25,588.0000 | 152,190,000 | 68.70% | 0.01% |
| June 12, 2025 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Not found | M | Restricted Stock Units | 10420 | $0.00 | 0.0000 | 152,190,000 | 100.00% | 0.01% |
| June 5, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | A | Stock Options (right to buy) | 74872 | $0.00 | 74,872.0000 | 300,116,081 | 9999.99% | 0.02% |
| June 5, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | A | Common Stock | 20414 | $0.00 | 91,550.0000 | 300,116,081 | 28.70% | 0.01% |
| Sept. 30, 2024 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | A | Common Stock | 778 | $12.77 | 13,990.0000 | 100,768,000 | 5.89% | 0.00% |
| Dec. 31, 2024 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | A | Common Stock | 1178 | $8.61 | 15,168.0000 | 160,049,000 | 8.42% | 0.00% |
| March 31, 2024 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | A | Common Stock | 2029 | $4.90 | 5,829.0000 | 100,768,000 | 53.39% | 0.00% |
| June 30, 2024 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | A | Common Stock | 713 | $13.93 | 13,212.0000 | 100,768,000 | 5.70% | 0.00% |
| June 12, 2024 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Not found | A | Stock Option (Right to Buy) | 15630 | $15.86 | 15,630.0000 | 100,768,000 | 9999.99% | 0.02% |
| June 12, 2024 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Not found | A | Restricted Stock Units | 10420 | $0.00 | 10,420.0000 | 100,768,000 | 9999.99% | 0.01% |
| June 12, 2024 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Not found | M | Common Stock | 6670 | $0.00 | 10,470.0000 | 100,768,000 | 175.53% | 0.01% |
| June 12, 2024 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Not found | M | Restricted Stock Units | 6670 | $0.00 | 0.0000 | 100,768,000 | 100.00% | 0.01% |
| June 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | A | Stock Options (right to buy) | 42467 | $0.00 | 42,467.0000 | 295,164,515 | 9999.99% | 0.01% |
| June 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | A | Common Stock | 11847 | $0.00 | 71,136.0000 | 295,164,515 | 19.98% | 0.00% |
| March 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | M | Common Stock | 7500 | $2.80 | 66,789.0000 | 295,164,515 | 12.65% | 0.00% |
| March 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | S | Common Stock | 7500 | $13.29 | 59,289.0000 | 295,164,515 | 11.23% | 0.00% |
| March 5, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | M | Common Stock | 7500 | $2.80 | 66,789.0000 | 295,164,515 | 12.65% | 0.00% |
| March 5, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | S | Common Stock | 7500 | $13.40 | 59,289.0000 | 295,164,515 | 11.23% | 0.00% |
| March 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | M | Stock Options (right to buy) | 7500 | $0.00 | 7,500.0000 | 295,164,515 | 50.00% | 0.00% |
| March 5, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Not found | M | Stock Options (right to buy) | 7500 | $0.00 | 0.0000 | 295,164,515 | 100.00% | 0.00% |
| June 12, 2023 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | A | Restricted Stock Units | 6670 | $0.00 | 6,670.0000 | 78,183,000 | 9999.99% | 0.01% |
| June 10, 2023 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | M | Common Stock | 3100 | $0.00 | 3,800.0000 | 78,183,000 | 442.86% | 0.00% |
| June 10, 2023 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | M | Restricted Stock Units | 3100 | $0.00 | 0.0000 | 78,183,000 | 100.00% | 0.00% |
| June 12, 2023 | NOVAVAX INC | $NVAX | MCGLYNN MARGARET G | Director | A | Stock Option (Right to Buy) | 7710 | $0.00 | 7,710.0000 | 78,183,000 | 9999.99% | 0.01% |
| June 8, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Director | A | Common Stock | 8584 | $0.00 | 59,289.0000 | 289,057,198 | 16.93% | 0.00% |
| June 8, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Director | A | Stock Options (right to buy) | 30474 | $0.00 | 30,474.0000 | 289,057,198 | 9999.99% | 0.01% |
| Jan. 13, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Director | M | Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 289,057,198 | 100.00% | 0.01% |
| Jan. 13, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Director | M | Common Stock | 15000 | $3.32 | 65,705.0000 | 289,057,198 | 29.58% | 0.01% |
| Jan. 13, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | MCGLYNN MARGARET G | Director | S | Common Stock | 15000 | $13.03 | 50,705.0000 | 289,057,198 | 22.83% | 0.01% |